Anti-citrullinated protein antibodies (ACPA), which recognize a group of post-transcriptionally modified autoantigens in RA, contribute to platelet activation and activated platelets release ADP themselves, further causing platelet activation (57). Here, PRTN3 is linked to rheumatoid arthritis.